New painkiller may cut opioid use after eye removal
NCT ID NCT02381353
First seen Jan 12, 2026 · Last updated May 16, 2026 · Updated 17 times
Summary
This study compares a slow-release painkiller (Exparel) to the standard painkiller (bupivacaine) for pain after eye removal surgery. About 88 adults having their eye removed will be randomly assigned to receive one of the two medications during surgery. The goal is to see if the slow-release version provides better pain control and reduces the need for opioid pain pills in the first few days after surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN, POSTOPERATIVE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
-
University of Michigan Kellogg Eye Institute
Ann Arbor, Michigan, 48109, United States
Conditions
Explore the condition pages connected to this study.